Plan A Wealth LLC Sells 3,962 Shares of VanEck Biotech ETF $BBH

Plan A Wealth LLC cut its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH) by 56.2% during the third quarter, HoldingsChannel.com reports. The firm owned 3,087 shares of the company’s stock after selling 3,962 shares during the quarter. Plan A Wealth LLC’s holdings in VanEck Biotech ETF were worth $511,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Farther Finance Advisors LLC lifted its holdings in VanEck Biotech ETF by 66.1% in the third quarter. Farther Finance Advisors LLC now owns 201 shares of the company’s stock valued at $33,000 after buying an additional 80 shares during the period. Caldwell Trust Co bought a new stake in shares of VanEck Biotech ETF during the 2nd quarter valued at $34,000. Flagship Harbor Advisors LLC lifted its stake in shares of VanEck Biotech ETF by 12.9% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 2,460 shares of the company’s stock valued at $377,000 after purchasing an additional 281 shares during the period. Rockefeller Capital Management L.P. lifted its stake in shares of VanEck Biotech ETF by 2.6% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 11,811 shares of the company’s stock valued at $1,811,000 after purchasing an additional 294 shares during the period. Finally, Altfest L J & Co. Inc. boosted its position in shares of VanEck Biotech ETF by 3.8% in the 3rd quarter. Altfest L J & Co. Inc. now owns 8,852 shares of the company’s stock worth $1,467,000 after purchasing an additional 322 shares during the last quarter. Institutional investors and hedge funds own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Down 1.1%

Shares of VanEck Biotech ETF stock opened at $195.86 on Wednesday. The business has a fifty day simple moving average of $193.64 and a 200 day simple moving average of $180.51. VanEck Biotech ETF has a 12 month low of $135.34 and a 12 month high of $202.91.

VanEck Biotech ETF Announces Dividend

The business also recently declared an annual dividend, which was paid on Friday, December 26th. Stockholders of record on Monday, December 22nd were paid a $0.9565 dividend. The ex-dividend date of this dividend was Monday, December 22nd. This represents a dividend yield of 50.0%.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.